Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9J. H. M. Schellens, A-R Hanauske, Jim Cassidy et al.|Anti-Cancer Drugs|2001Cited by 13